World Leader Dr. Henriette Coetzer Joins RowdMap, Inc. as Chief Clinical Risk Officer to Help Health Plans and Physicians Transition to Pay-for-Value Arrangements

Share Article

RowdMap, Inc. introduces Dr. Henriette Coetzer as Chief Clinical Risk Officer to Help Health Plans and Physicians Transition to Pay-for-Value Arrangements. Dr. Coetzer is a world leader in using public health data to create transparency and transform healthcare practices and policies creating interventions.

News Image
The work Dr. Coetzer is doing on clinical risk is crucial to RowdMap, Inc.’s mission. Few people in the world have the unique combination of skills, expertise and experience and that’s why we are ecstatic to have Dr. Coetzer on board.

Dr. Henriette Coetzer is an influential name in using health data to create transparency in healthcare practices and policies. Her extensive and personal history with diverse clinical practices, data and policy is particularly well-suited for her work with RowdMap, Inc. to help health plans, government payers, providers, and hospital systems develop Risk-Readiness strategies to excel as they transition from fee-for-service to pay-for-value. Perhaps best known for her pioneering work on the Dartmouth Atlas of Unwarranted Variation at BUPA (British United Provident Association) and Health Dialog where she served as VP of Clinical Analytics, Dr. Coetzer has served as Global Medical Director at Towers Watson and product development at Healthways. She serves as a Director of Clinical Transformation for the National Health Service (NHS) in the United Kingdom at a Clinical Commissioning Group (CCG), the Accountable Care Organizations (ACOs) of the United Kingdom. She also practices as an urgent care physician.

Dr. Coetzer's clinical expertise is grounded in a diverse medical practice. After receiving her medical degree, she worked in South Africa on academic medicine and health policy, then in Canada as a flying doctor providing emergency and obstetric care. She has taught at School of Actuarial Science at the University of Cape Town, inspiring her to work on predicting key transitions in health and care trajectories by looking for life-time value indicators for quality medical care.

Her expertise in clinical information, and the impact of cost and risk on system transformation, has been repeatedly recognized. In January of 2015, she was granted a patent on a clinically-driven approach to reducing unnecessary primary admissions. This method involves using clinical indicators to identify health care providers and their practice patterns in light of unnecessary or preventable inpatient admissions: http://patents.justia.com/patent/20150019255

Dr. Coetzer joined RowdMap, Inc.’s Board of Advisers in 2014 and will continue in that position as she now takes on the office of Chief Clinical Risk Officer where she is responsible for bringing together clinical practice and economic drivers and impact both at an individual physician level as well as across an ecosystem. “The work Dr. Coetzer is doing on clinical risk is crucial to RowdMap, Inc.’s mission. Few people in the world have the unique combination of skills, expertise and experience to handle RowdMap Inc.’s mission to use public data to help health plans and providers transition to pay-for-value arrangements and that’s why we are ecstatic to have Dr. Coetzer as part of RowdMap Inc.’s senior leadership.” Melanie Rosenthal, Chief Executive Officer, RowdMap, Inc.

Dr. Coetzer's new role will directly support RowdMap, Inc.’s mission to help health plans, government payers, providers, and hospital systems develop Risk-Readiness strategies to excel as they transition from Fee-For-Service to Pay-For-Value. The Centers for Medicare and Medicaid Services (CMS) has announced that 50% of spending will turn away from fee for service and direct it towards risk arrangement models that focus on pay for value care practices: http://www.hhs.gov/news/press/2015pres/01/20150126a.html CMS has recently begun to directly transform payment to value based arrangements, beginning with the episodes with some of the largest amounts of unnecessary spending such as orthopedics: http://www.hhs.gov/news/press/2015pres/07/20150709.html CMS has also released historic data sets on providers to enable identifying providers and their practices patterns to make this transition: https://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-releases/2015-Press-releases-items/2015-06-01.html

RowdMap works with health plans, hospitals and groups of physicians to profile unnecessary spend and no value care in their populations and within their networks of physicians, then matches this to the best risk arrangements and Pay-for-Value programs for their populations and performance. RowdMap, Inc. has Risk-Readiness (SM) national and regional benchmarks for every physician, group, network, hospital and post-acute center in the United States, pre-loaded and ready to go with no dependencies on a health plan or physician's Information Technology capabilities. Dr. Coetzer's experience with diverse populations, clinical understanding, and revolutionary healthcare data analytics makes her a key player in this time where there is a dire need for innovation in healthcare management strategies.

About RowdMap, Inc. :
An Ernst and Young EY Entrepreneur Of The Year® winner, RowdMap helps health plans, government payers, providers, and hospital systems develop Risk-Readiness (SM) strategies to excel as they transition from fee-for- service to pay-for value. As CMS sunsets fee-for-service payments, RowdMap's Risk-Readiness (SM) Platform helps payers and providers identify and manage unwarranted and unexpected variation. RowdMap identifies ideal provider arrangements based on provider practice patterns and population characteristics within a geography. Payers and providers then use RowdMap to build strategies around these new risk relationships. RowdMap helps them enter new markets, segment populations, identify waste, design products, and understand referral patterns. RowdMap's platform comes preloaded with government benchmarks out of the box no IT integration required. RowdMap's Risk-Readiness (SM) Platform works across all market segments and has significantly larger returns than traditional, medical economic approaches.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joshua Rosenthal
Visit website